<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T17:59:40Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5788970" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5788970</identifier>
        <datestamp>2018-02-08</datestamp>
        <setSpec>frontphysiol</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Front Physiol</journal-id>
              <journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id>
              <journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
              <journal-title-group>
                <journal-title>Frontiers in Physiology</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1664-042X</issn>
              <publisher>
                <publisher-name>Frontiers Media S.A.</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5788970</article-id>
              <article-id pub-id-type="pmcid">PMC5788970</article-id>
              <article-id pub-id-type="pmc-uid">5788970</article-id>
              <article-id pub-id-type="pmid">29422872</article-id>
              <article-id pub-id-type="doi">10.3389/fphys.2018.00040</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Physiology</subject>
                  <subj-group>
                    <subject>Original Research</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Myocardial CKIP-1 Overexpression Protects from Simulated Microgravity-Induced Cardiac Remodeling</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ling</surname>
                    <given-names>Shukuan</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="author-notes" rid="fn003">
                    <sup>†</sup>
                  </xref>
                  <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/383057/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Yuheng</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="author-notes" rid="fn003">
                    <sup>†</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zhong</surname>
                    <given-names>Guohui</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="author-notes" rid="fn003">
                    <sup>†</sup>
                  </xref>
                  <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/284040/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zheng</surname>
                    <given-names>Yongjun</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Xu</surname>
                    <given-names>Qing</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zhao</surname>
                    <given-names>Dingsheng</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sun</surname>
                    <given-names>Weijia</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jin</surname>
                    <given-names>Xiaoyan</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Hongxing</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff4">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Jianwei</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sun</surname>
                    <given-names>Huiyuan</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff5">
                    <sup>5</sup>
                  </xref>
                  <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/477455/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cao</surname>
                    <given-names>Dengchao</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff6">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Song</surname>
                    <given-names>Jinping</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Liu</surname>
                    <given-names>Caizhi</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yuan</surname>
                    <given-names>Xinxin</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff6">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wu</surname>
                    <given-names>Xiaorui</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zhao</surname>
                    <given-names>Yinlong</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff4">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Liu</surname>
                    <given-names>Zizhong</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                  <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/200051/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Qi</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Yingxian</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="author-notes" rid="fn001">
                    <sup>*</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff1"><sup>1</sup><institution>State Key Lab of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
              <aff id="aff2"><sup>2</sup><institution>Medical Administration Division, The 261th Hospital of PLA</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
              <aff id="aff3"><sup>3</sup><institution>Core Facility Center, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
              <aff id="aff4"><sup>4</sup><institution>Key Laboratory of Molecular and Cellular Biology of Ministry of Education, College of Life Science, Hebei Normal University</institution>, <addr-line>Shijiazhuang</addr-line>, <country>China</country></aff>
              <aff id="aff5"><sup>5</sup><institution>Xiyuan Hospital, China Academy of Chinese Medical Sciences</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
              <aff id="aff6"><sup>6</sup><institution>State Key Laboratory of Agrobiotechnology, College of Life Sciences, China Agricultural University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
              <author-notes>
                <fn fn-type="edited-by">
                  <p>Edited by: Andreas Roessler, Medical University of Graz, Austria</p>
                </fn>
                <fn fn-type="edited-by">
                  <p>Reviewed by: Mitchel Tate, Baker Heart and Diabetes Institute, Australia; Mónica Isa Moreira-Rodrigues, University of Porto, Portugal</p>
                </fn>
                <corresp id="fn001">*Correspondence: Yingxian Li <email xlink:type="simple">yingxianli@aliyun.com</email></corresp>
                <fn fn-type="other" id="fn002">
                  <p>This article was submitted to Integrative Physiology, a section of the journal Frontiers in Physiology</p>
                </fn>
                <fn fn-type="other" id="fn003">
                  <p>†These authors have contributed equally to this work.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>25</day>
                <month>1</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2018</year>
              </pub-date>
              <volume>9</volume>
              <elocation-id>40</elocation-id>
              <history>
                <date date-type="received">
                  <day>14</day>
                  <month>9</month>
                  <year>2017</year>
                </date>
                <date date-type="accepted">
                  <day>11</day>
                  <month>1</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2018 Ling, Li, Zhong, Zheng, Xu, Zhao, Sun, Jin, Li, Li, Sun, Cao, Song, Liu, Yuan, Wu, Zhao, Liu, Li and Li.</copyright-statement>
                <copyright-year>2018</copyright-year>
                <copyright-holder>Ling, Li, Zhong, Zheng, Xu, Zhao, Sun, Jin, Li, Li, Sun, Cao, Song, Liu, Yuan, Wu, Zhao, Liu, Li and Li</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Human cardiovascular system has adapted to Earth's gravity of 1G. The microgravity during space flight can induce cardiac remodeling and decline of cardiac function. At present, the mechanism of cardiac remodeling induced by microgravity remains to be disclosed. Casein kinase-2 interacting protein-1 (CKIP-1) is an important inhibitor of pressure-overload induced cardiac remodeling by decreasing the phosphorylation level of HDAC4. However, the role of CKIP-1 in the cardiac remodeling induced by microgravity is unknown. The purpose of this study was to determine whether CKIP-1 was also involved in the regulation of cardiac remodeling induced by microgravity. We first detected the expression of CKIP-1 in the heart from mice and monkey after simulated microgravity using Q-PCR and western blotting. Then, myocardial specific CKIP-1 transgenic (TG) and wild type mice were hindlimb-suspended (HU) to simulate microgravity effect. We estimated the cardiac remodeling in morphology and function by histological analysis and echocardiography. Finally, we detected the phosphorylation of AMPK, ERK1/2, and HDAC4 in the heart from wild type and CKIP-1 transgenic mice after HU. The results revealed the reduced expression of CKIP-1 in the heart both from mice and monkey after simulated microgravity. Myocardial CKIP-1 overexpression protected from simulated microgravity-induced decline of cardiac function and loss of left ventricular mass. Histological analysis demonstrated CKIP-1 TG inhibited the decreases in the size of individual cardiomyocytes of mice after hindlimb unloading. CKIP-1 TG can inhibit the activation of HDAC4 and ERK1/2 and the inactivation of AMPK in heart of mice induced by simulated microgravity. These results demonstrated CKIP-1 was a suppressor of cardiac remodeling induced by simulated microgravity.</p>
              </abstract>
              <kwd-group>
                <kwd>CKIP-1</kwd>
                <kwd>simulated microgravity</kwd>
                <kwd>cardiac remodeling</kwd>
                <kwd>HDAC4</kwd>
                <kwd>AMPK</kwd>
                <kwd>ERK1/2</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source>
                  <award-id rid="cn001">31670865</award-id>
                  <award-id rid="cn001">31300698</award-id>
                  <award-id rid="cn001">31325012</award-id>
                </award-group>
                <award-group>
                  <funding-source id="cn002">Beijing Nova Program<named-content content-type="fundref-id">10.13039/501100005090</named-content></funding-source>
                  <award-id rid="cn002">Z161100004916111</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="0"/>
                <equation-count count="0"/>
                <ref-count count="35"/>
                <page-count count="11"/>
                <word-count count="6325"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="s1">
              <title>Introduction</title>
              <p>Human cardiovascular system has adapted to Earth's gravity of 1G, and cardiac muscle is well regulated in response to changes in loading conditions (Tuday and Berkowitz, <xref rid="B26" ref-type="bibr">2007</xref>; Hill and Olson, <xref rid="B11" ref-type="bibr">2008</xref>). When exposed to microgravity during space flight, there are various changes in cardiac mass and cardiac systolic volume (Hill and Olson, <xref rid="B11" ref-type="bibr">2008</xref>). Microgravity can induce the chronic reduction in metabolic demand and oxygen uptake which reduces the demand on cardiac output, resulting in cardiac atrophy and the decline of cardiac function (Dorfman et al., <xref rid="B9" ref-type="bibr">2007</xref>; Zhong G. et al., <xref rid="B34" ref-type="bibr">2016</xref>; Zhong G. H. et al., <xref rid="B33" ref-type="bibr">2016</xref>). There are many important factors which can regulate cardiac remodeling induced by external or intrinsic stimuli, including AMPK, ERK1/2, and HDAC4 (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>; Ruppert et al., <xref rid="B23" ref-type="bibr">2013</xref>; Myers et al., <xref rid="B19" ref-type="bibr">2017</xref>). Our previous study demonstrated that pathological cardiac remodeling signals, such as HDAC4 and ERK1/2, were activated, and physiological cardiac remodeling signals, such as AMPK, were inactivated in heart of mice after hindlimb unloading, which might lead to cardiac remodeling and decline of heart function (Zhong G. et al., <xref rid="B34" ref-type="bibr">2016</xref>). Beyond that, we know little about the mechanisms regulating cardiac atrophy induced by microgravity. Also, the prevention of cardiac remodeling induced by simulated microgravity via inhibiting the changes of these signals activity need to be elucidated.</p>
              <p>The PH domain-containing casein kinase 2 interacting protein-1 (CKIP-1) was first identified as an interactive protein of casein kinase 2a (Bosc et al., <xref rid="B3" ref-type="bibr">2000</xref>), and functions as a scaffold protein integrating multiple signaling pathways and is highly expressed in the heart under physiological functions (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>). CKIP-1 was implicated in tumor cell proliferation (Zhu et al., <xref rid="B35" ref-type="bibr">2017</xref>), muscle cell differentiation (Safi et al., <xref rid="B24" ref-type="bibr">2004</xref>), cell apoptosis (Zhang et al., <xref rid="B32" ref-type="bibr">2005</xref>), the regulation of cell morphology (Canton et al., <xref rid="B5" ref-type="bibr">2006</xref>), and the actin cytoskeleton (Canton et al., <xref rid="B4" ref-type="bibr">2005</xref>). We previously showed that CKIP-1 functioned as a novel regulator of pathological cardiac remodeling induced by pressure overload (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>). We found that CKIP-1-deficent mice displayed age-dependent cardiac hypertrophy and decline of cardiac function. Pressure overload-induced cardiac hypertrophy was exaggerated in CKIP-1-deficient mice. Moreover, myocardial-specific CKIP-1 overexpression protects from cardiac hypertrophy induced by pressure overload. The anti-hypertrophic effects of CKIP-1 are mediated by dephosphorylation and nuclear retention of HDAC4. CKIP-1 is a potential target for inhibiting cardiac remodeling induced by pressure overload (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>). As with other form of cardiac- remodeling cardiac hypertrophy induced by pressure overload, cardiac atrophy induced by microgravity although linked with different phenotypes (atrophy vs. hypertrophy), generate interesting similar changes-upregulation of cardiac remodeling marker genes and decline of cardiac function (Depre et al., <xref rid="B8" ref-type="bibr">1998</xref>). However, the role of CKIP-1 in cardiac remodeling induced by microgravity was unknown.</p>
              <p>In this study, we found CKIP-1 mRNA and protein levels in hearts of mice and rhesus monkeys after simulated microgravity were significantly decreased. The results showed myocardial CKIP-1 overexpression protected from the decline of cardiac function, the atrophy of cardiomyocyte and changes in phosphorylation levels of signal factors induced by simulated microgravity. We demonstrated myocardial CKIP-1 overexpression protected from cardiac remodeling induced by simulated microgravity.</p>
            </sec>
            <sec sec-type="materials and methods" id="s2">
              <title>Materials and methods</title>
              <sec>
                <title>Animal experiments</title>
                <p>All animal studies were performed according to approved guidelines for the use and care of live animals (Guideline on Administration of Laboratory Animals released in1988 and 2006 Guideline on Humane Treatment of Laboratory Animals from China, and also referring to European Union guideline 2010/63). The experimental procedures were approved by the Animal Care and Use Committee of China Astronaut Research and Training Center.</p>
                <p>The healthy rhesus monkeys with body weight of 5–8 kg and 4–8 years old were purchased from Beijing Xieerxin Biology Resource (Beijing, China). The monkeys were maintained−10-degree head-down tilt position for 42 days. The whole process were supervised and monitored 24 h/day. This 42-day bed rest experiment of rhesus monkeys have been reported previously (Chen et al., <xref rid="B6" ref-type="bibr">2016</xref>).</p>
                <p>Myocardial-specific CKIP-1 transgenic mice have been reported previously (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>). All WT and CKIP-1 transgenic (TG) mice used in this study were bred and housed at the specific-pathogen-free (SPF) Animal Research Center of China Astronaut Research and Training Center (12:12-h light-dark cycle, temperature: 23°C). All the experiments were repeated three times performed with CKIP-1 mice (2 month) and age-matched WT controls. The hindlimbs of hindlimb-unloading procedure were elevated by tail suspension, as described before (Zhong G. et al., <xref rid="B34" ref-type="bibr">2016</xref>). Briefly, the 2 months old mice were maintained in individual cage and suspended with a strip attached the tail and linked a chain hanging from a pulley. The mice were elevated to an angle of 30° to the ground, and only the forelimbs of mice can touch the floor, so the hindlimb-unloading mice can move freely to eat and drink. The mice were retained to hindlimb unloading by tail suspension for 28 days, the height of hindlimb suspension was modulated to prevent the hinklimb from touching the ground. This is identified as the “unloaded” state. Similar numbers of control mice of the age-matched littermates and the same strain background were instrumented and monitored in the identical cage conditions without tail suspension.</p>
              </sec>
              <sec>
                <title>Histological analysis</title>
                <p>Sections were generated from paraffin embedded hearts, and were stained with H&amp;E for gross morphology, Masson's trichrome for detection of fibrosis, Frozen sections were used to visualize cardiomyocyte cell membranes by staining with TRITC-conjugated wheat-germ agglutinin (Sigma-Aldrich), as described before (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>).</p>
              </sec>
              <sec>
                <title>RNA extraction and real-time polymerase chain reaction</title>
                <p>Total RNA was extracted from heart tissues by using RNAiso Plus reagent (Takara) according to the manufacturer's protocol. The RNA was reverse transcribed into cDNA, and qPCR was performed using a SYBR Green PCR kit (Takara) in a Light Cycler (LightCycler 96, Roche, USA). The mRNA level of each gene was normalized to that of Gapdh, which served as an internal control. Primers (synthesized by Sunbiotech Co, China) for <italic>Col1a1, Col3a1</italic>, BNP, <italic>Ckip1</italic>, and <italic>Gapdh</italic> were as follows:</p>
                <p>Mouse:</p>
                <list list-type="simple">
                  <list-item>
                    <p><italic>Col1a1</italic> sense primer: 5′-CTGACTGGAAGAGCGGAGAGT-3′,</p>
                  </list-item>
                  <list-item>
                    <p><italic>Col1a1</italic> anti-sense primer: 5′-AGACGGCTGAGTAGGGAACAC-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>Col3a1</italic> sense primer: 5′-ACGTAAGCACTGGTGGACAG-3′,</p>
                  </list-item>
                  <list-item>
                    <p><italic>Col3a1</italic> anti-sense primer: 5′-CAGGAGGGCCATAGCTGAAC-3′;</p>
                  </list-item>
                  <list-item>
                    <p>BNP sense primer: 5′-TGTTTCTGCTTTTCCTTTATCTG-3′,</p>
                  </list-item>
                  <list-item>
                    <p>BNP anti-sense primer: 5′-TCTTTTTGGGTGTTCTTTTGTGA-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>CKIP-1</italic> sense primer: 5′-GCCGTGAGTCCTGAAGAGAAG-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>CKIP-1</italic> anti-sense primer: 5′-CGAGTAGGGTGGGCAAGATAG-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>Gapdh</italic> sense primer: 5′-ACTCCACTCACGGCAAATTCA-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>Gapdh</italic> anti-sense primer: 5′-GGCCTCACCCCATTTGATG-3′.</p>
                  </list-item>
                </list>
                <p>Monkey:</p>
                <list list-type="simple">
                  <list-item>
                    <p><italic>Col1a1</italic> sense primer: 5′-TGACGAGACCAAGAACTGCC-3′,</p>
                  </list-item>
                  <list-item>
                    <p><italic>Col1a1</italic> anti-sense primer: 5′-CAGGAGATTACCTCGACGCC-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>Col3a1</italic> sense primer: 5′-CAAAAGGGGAGCTGGCTACT-3′,</p>
                  </list-item>
                  <list-item>
                    <p><italic>Col3a1</italic> anti-sense primer: 5′-CAACAGCTTCCTGTTGTGCC-3′;</p>
                  </list-item>
                  <list-item>
                    <p>BNP sense primer: 5′-AATGGTCCTGTACACCCTGC-3′,</p>
                  </list-item>
                  <list-item>
                    <p>BNP anti-sense primer: 5′-ATCTTCCTCCCAAAGCAGCC-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>CKIP-1</italic> sense primer: 5′-TCAGGATGGAAACCAGCA-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>CKIP-1</italic> anti-sense primer: 5′-TTCAGCACCACATAGCGGT-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>Gapdh</italic> sense primer: 5′-CGAGAGTCAGCCGCATTTTC-3′;</p>
                  </list-item>
                  <list-item>
                    <p><italic>Gapdh</italic> anti-sense primer: 5′-GACTCCGACCTTCACCTTCC-3′.</p>
                  </list-item>
                </list>
              </sec>
              <sec>
                <title>Echocardiography</title>
                <p>Animals were lightly anesthetized with 2,2,2-tribromoethanol (0.2 ml/10 g body weight of a 1.2% solution) and set in a supine position. Two dimensional (2D) guided M-mode echocardiography was performed using a high resolution imaging system (Vevo 2100, Visual-Sonics Inc., Toronto, ON, Canada). Two-dimensional images are recorded in parasternal long- and short-axis projections with guided M-mode recordings at the midventricular level in both views. Left ventricular (LV) cavity size and wall thickness are measured in at least three beats from each projection. Averaged LV wall thickness [anterior wall (AW) and posterior wall (PW) thickness] and internal dimensions at diastole and systole (LVIDd and LVIDs, respectively) are measured. LV fractional shortening ((LVIDd–LVIDs)/LVIDd), relative wall thickness ((IVS thickness + PW thickness)/LVIDd), and LV mass (LV Mass = 1.053 × [(LVID;d + LVPW;d + IVS;d)3 – LVID;d3) are calculated from the M-mode measurements. LV ejection fraction (EF) wascalculated from the LV cross-sectional area (2-D short-axis view) using the equation LV%EF = (LV Vol;d – LV Vol;s)/LV Vol;d × 100%. The studies and analysis were performed blinded as to experimental groups. Structure and function of LV were assessed as described before (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>).</p>
              </sec>
              <sec>
                <title>Western blot analysis</title>
                <p>Hearts of mouse and monkey were crushed by homogenizer (Power Gen125, Fisher Scientific) and then lysed in lysis buffer (50 mM Tris, pH 7.5, 250 mM NaCl, 0.1% SDS, 2 mM dithiothreitol, 0.5% NP-40, 1 mM PMSF and protease inhibitor cocktail) on ice for 15 min. Protein fractions were collected by centrifugation for 15 min (12,000 g, 4°C) and then applied to 10% SDS-PAGE gels, electrophoresed at 80 V for 30 min and 120 V for 90 min. After electrophoresis, protein was transfected to a polyvinylidene fluoride membrane using a Criterion blotter apparatus (Bio Rad). The membrane was then blocked in 5% non-fat dry milk (Becton, Dickinson and Company) in TBST (10 mM Tris–Cl, 150 mM NaCl, 0.05% Tween-20, pH 7.5) for 2 h. After that, the membrane was incubated with primary antibody overnight at 4°Cfollowed by incubation with a secondary antibody conjugated to horseradish peroxidase (HRP), and visualized using an chemiluminescence kit (Thermo Pierce, No.32 109). Specific antibodies to p-HDAC4 (Cell Signaling Technology, #3443S), HDAC4 (Cell Signaling Technology, #5392S), p-AMPKα (Cell Signaling Technology, #2531S), AMPKα (Cell Signaling Technology, #2532), p-ERK1/2 (Cell Signaling Technology, #4370S), ERK1/2 (Cell Signaling Technology, #4696S), CKIP-1 (proteintech, #24883-1), Gapdh (Santa Cruz Biotechnology, sc-25778) were used to detect protein levels. Gapdh was used as a loading control.</p>
              </sec>
              <sec>
                <title>Statistical analysis</title>
                <p>Data are presented as mean ± SEM per experimental condition. Statistical differences among groups were analyzed by one-way analysis of variance with a <italic>post-hoc</italic> test to determine group differences in the study parameters. Statistical differences between two groups were determined by the Student's <italic>t</italic>-test. We use the two-way analysis of variance with unequal variances to account for 2 factors and their interactions. Firstly, we test the equality of variances using a factorial effects analysis of variance on the absolute values of the residuals. If the variances are unequal, we then fit a mixed model with heterogeneous variances. Otherwise, we use the regular linear model. Bonferroni adjustment was used for multiple comparisons. <italic>P</italic> &lt; 0.05 is considered statistically significant. All the statistical tests are analyzed by Prism software (Graphpad prism for windows, version 5.01) and SPSS (Version 14.0).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="s3">
              <title>Results</title>
              <sec>
                <title>The changes of CKIP-1 expression in the hearts of mice and rhesus monkeys after simulated microgravity</title>
                <p>To assess the potential role of CKIP-1 in cardiac remodeling induced by simulated microgravity, hearts from mice after 28 days of hindlimb unloading were assessed for CKIP-1 expression. As shown in Figures <xref ref-type="fig" rid="F1">1A,B</xref>, CKIP-1 mRNA and protein levels were significantly decreased in the hearts of mice after hindlimb unloading. Simulated microgravity can downregulate CKIP-1 expression in mice heart. Moreover, we detected CKIP-1 expression in hearts of rhesus monkeys after 45 days of bed rest. Firstly, real-time polymerase chain reaction analysis showed that the transcripts of the pathological cardiac remodeling genes-Col1a1, Col3a1, BNP, and β-MHC were constantly increased in the hearts of monkey after bed rest, however no obvious changes were showed in α-MHC mRNA level (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">1</xref>). And the changes in phosphorylation levels of HDAC4, AMPK, and ERK1/2 which were proved to be involved in cardiac remodeling of mice after hind limb unloading were detected in hearts of rhesus monkey after 45 days of bed rest. The results showed that following 45 days of bed rest, pathological cardiac remodeling signals-HDAC4 and ERK1/2 were activated, and physiological cardiac remodeling signal-AMPK were inactivated in monkey hearts (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">2</xref>). Meantime, CKIP-1 mRNA and protein levels were also significantly decreased in the hearts of rhesus monkeys after bed rest (Figures <xref ref-type="fig" rid="F1">1C,D</xref>). These results indicated that simulated microgravity reduced the mRNA and protein levels of CKIP-1 which was a suppressor of pathological cardiac remodeling.</p>
                <fig id="F1" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>CKIP-1 expression changes in in the hearts of mice and rhesus monkeys after simulated microgravity. <bold>(A)</bold> CKIP-1 mRNA levels change in left ventricle of mice after 28 days hindlimb unloading (<italic>n</italic> = 6). <bold>(B)</bold> Representative Western blotting analysis of CKIP-1 expression in cardiac extracts of adult mice after 28 days hindlimb unloading. <bold>(C)</bold> CKIP-1 mRNA levels change in left ventricle of rhesus monkeys following 45 days of head-down bed rest (<italic>n</italic> = 3). <bold>(D)</bold> Western blotting analysis of CKIP-1 expression in cardiac extracts of rhesus monkey after 45 days bed rest. <sup>**</sup><italic>P</italic> &lt; 0.01, <sup>*</sup><italic>P</italic> &lt; 0.05.</p>
                  </caption>
                  <graphic xlink:href="fphys-09-00040-g0001"/>
                </fig>
              </sec>
              <sec>
                <title>Myocardial CKIP-1 overexpression protects from simulated microgravity induced-decline of cardiac function</title>
                <p>To further investigate the potential role of CKIP-1 as a suppressor of cardiac remodeling induced by simulated microgravity, we utilized the transgenic (TG) mice with CKIP-1-specific overexpression in cardiomyocytes by using α-MHC promoter. Wildtype (WT) and CKIP-1 TG littermates at 2 months of age were subjected to hindlimb unloading by tail suspension for 28 days. The relevant control groups were treated equally, with the exception of tail suspension. Body weight, heart weight and left ventricular mass were recorded (Figures <xref ref-type="fig" rid="F2">2A–C</xref>), heart rate and cardiac function were calculated by echocardiography (Figures <xref ref-type="fig" rid="F2">2D–F</xref>). All echocardiographic measurements were made while the heart rates of mice were maintained at 400–500 beats per minute (Figure <xref ref-type="fig" rid="F2">2D</xref>). The two way ANOVA was carried out on left ventricular mass, left ventricular fractional shortening (FS), and left ventricular ejection fraction (EF) by condition (control / hindlimb unloading) and genotype (WT/TG). There were all statistically significant interactions between the effects of condition and genotype on left ventricular mass, EF and FS. Compared with the control group, left ventricular mass of WT mice after hindlimb unloading were significantly reduced, meantime left ventricular FS and EF decreased significantly in WT after hindlimb unloading. In comparison with WT mice, CKIP-1 TG mice exhibited a decreased response to hindlimb unload. The changes in left ventricular mass, EF and FS of TG mice after hindlimb were not apparent, and the values were higher than WT-HU group. These results indicated that myocardial CKIP-1 overexpression protected from simulated microgravity induced-decline of cardiac function and loss of left ventricular mass.</p>
                <fig id="F2" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <p>Myocardial CKIP-1 overexpression protects from simulated microgravity induced-the decline of cardiac function. Bodyweight <bold>(A)</bold>, left ventricular mass <bold>(B)</bold>, heart weight <bold>(C)</bold>, and heart rate <bold>(D)</bold> of wild type (WT) and CKIP-1 transgenic (TG) mice after 28 days hindlimb unloading. <bold>(E,F)</bold> Echocardiographic assessment of fractional shortening (FS) and ejection factor (EF) of WT and CKIP-1 transgenic mice after 28 days hindlimb unloading. Ctrl, control group; HU, mice following 28 days of hindlimb unloading; WT, wild type mice, TG, cardiac specific CKIP-1 transgenic mice. Values are means ± SEM, <italic>n</italic> = 6, <sup>*</sup><italic>P</italic> &lt; 0.05.</p>
                  </caption>
                  <graphic xlink:href="fphys-09-00040-g0002"/>
                </fig>
              </sec>
              <sec>
                <title>Transthoracic echocardiography assessing the left ventricular structure of WT and TG mice after 28 days of hindlimb unloading</title>
                <p>To validate the influence of CKIP-1 TG in the heart structure after hindlimb unloading, we performed transthoracic echocardiography to determine the left ventricular structure of WT and TG mice following hindlimb unloading (Figure <xref ref-type="fig" rid="F3">3A</xref>). A two way ANOVA was carried out on the end-diastolic left ventricular posterior wall thickness (LVPWd) by condition and genotype. There was a statistically significant interaction between the effects of condition and genotype on LVPWd. Compared with control, LVPWd of WT mice was decreased following hindlmb unloading, however LVPWd of TG mice after hindlimb unloading did not change, and the value was higher than that in WT mice after hindlimb unloading (Figure <xref ref-type="fig" rid="F3">3B</xref>). Meantime, the end-systolic left ventricular posterior wall thickness (LVPWs) (Figure <xref ref-type="fig" rid="F3">3C</xref>), the end- diastolic anterior wall thickness (LVAWd) (Figure <xref ref-type="fig" rid="F3">3D</xref>), the end-systolic anterior wall thickness (LVAWs) (Figure <xref ref-type="fig" rid="F3">3E</xref>), the end- diastolic LV internal diameter (LVIDs) (Figure <xref ref-type="fig" rid="F3">3F</xref>), and the end-systolic LV internal diameter (LVIDd) (Figure <xref ref-type="fig" rid="F3">3G</xref>) did not change in the WT and TG mice after hindlimb unloading. These data indicated that CKIP-1 TG protected from the shortening of LVPWd induced by hindlimb unloading.</p>
                <fig id="F3" position="float">
                  <label>Figure 3</label>
                  <caption>
                    <p>Transthoracic echocardiography evaluating the left ventricular structure of WT and TG mice following hindlimb unloading. <bold>(A)</bold> Representative M-model recordings of echocardiography. <bold>(B–G)</bold> Quantitative analysis of the diastolic and systolic left ventricular posterior wall thickness (LVPWd and LVPWs), LV anterior wal thickness (LVAWd and LVAWs), and LV internal diameter (LVIDd and LVIDs) from WT and TG mice by echocardiography following hindlimb unloading. Values are means ± SEM, <italic>n</italic> = 6, <sup>*</sup><italic>P</italic> &lt; 0.05.</p>
                  </caption>
                  <graphic xlink:href="fphys-09-00040-g0003"/>
                </fig>
              </sec>
              <sec>
                <title>Myocardial CKIP-1 overexpression protects from simulated microgravity induced-cardiac atrophy</title>
                <p>To address the effect of myocardial CKIP-1 overexpression on cardiac atrophy induced by hindlimb unloading, hearts from WT and TG mice were assessed for changes in morphology and cardiac remodeling genes expression. As shown in Figure <xref ref-type="fig" rid="F4">4A</xref>, in hematoxylin and eosin-stained (H&amp;E) sections, gross evidence of edema was easily observed by separation of the myofibers in the WT mice after hindlimb, however TG mice after hindlimb had no obvious change. Masson trichrome staining (MTT) showed a deeper staining of collagen in the heart of mice after hindlimb unloading, and CKIP-1 TG could inhibit this change. A two way ANOVA was carried out on myocyte cross sectional area by condition and genotype. There was a statistically significant interaction between the effects of condition and genotype on myocyte cross sectional area. Histological analysis demonstrated decreases in the size of individual cardiomyocytes of WT mice after hindlimb unloading, however, the cardiomyocytes of TG mice after hindlimb unloading had no obvious changes compared with control mice, and higher than WT HU group (Figure <xref ref-type="fig" rid="F4">4B</xref>). The two way ANOVA analysis reports showed there were statistically significant interactions between the effects of condition and genotype on the levels of Col1a1, Col3a1, and BNP mRNAs. The results showed that transcripts for the pathological cardiac remodeling genes-Col1a1, Col3a1, and BNP were significantly increased in the hearts of WT mice after hindlimb unloading, compared with WT control group. And myocardial CKIP-1 overexpression protected from the increases of cardiac remodeling genes expression induced by simulated microgravity (Figures <xref ref-type="fig" rid="F4">4C–E</xref>).</p>
                <fig id="F4" position="float">
                  <label>Figure 4</label>
                  <caption>
                    <p>Myocardial CKIP-1 overexpression protects from simulated microgravity induced-cardiac atrophy. <bold>(A)</bold> H&amp;E-stained sections of hearts from WT and CKIP-1 TG mice after 28 days of hindlimb unloading. Sections of hearts are stained with Masson trichrome (MTT) to detect fibrosis (blue). Wheat germ agglutinin (WGA) staining is used to demarcate cell boundaries. Scale bars: 50 μm. <bold>(B)</bold> The cardiomyocyte crosssectional area was measured from 8-μm-thick heart sections that had been stained with WGA by using ImageJ software (NIH). Only myocytes that were round were included in the analysis. The studies and analysis were performed blinded as to experimental. Data represent the means ± SEM (<italic>n</italic> = 6), <sup>*</sup><italic>P</italic> &lt; 0.05, <sup>**</sup><italic>P</italic> &lt; 0.01. <bold>(C–E)</bold> The mRNA levels of Col1a1, Col3a1, and BNP were analyzed by Q-PCR from WT and CKIP-1 TG mice after 28 days of hindlimb unloading. The relative abundance of transcripts were quantified and normalized to GAPDH. Data represent the means ± SEM (<italic>n</italic> = 6), <sup>*</sup><italic>P</italic> &lt; 0.05.</p>
                  </caption>
                  <graphic xlink:href="fphys-09-00040-g0004"/>
                </fig>
              </sec>
              <sec>
                <title>Myocardial CKIP-1 overexpression inhibits the changes of signaling pathway in mice heart induced by simulated microgravity</title>
                <p>To gain more insights into the effect of CKIP-1 overexpression on the signaling pathways involved in the cardiac remodeling induced by simulated microgravity, we examined the phosphorylation levels of AMPK, ERK1/2, and HDAC4 in heart tissues of WT and TG mice after hindlimb unloading (Figure <xref ref-type="fig" rid="F5">5A</xref>). The two way ANOVA analysis reports showed there were statistically significant interactions between the effects of condition and genotype on the phosphorylation levels of HDAC4 phosphorylation at Ser246 and Ser632, Erk1/2 phosphorylation at Thr202/Tyr204 and AMPK phosphorylation at Thr172. As shown in Figure <xref ref-type="fig" rid="F5">5B</xref>, quantifications of phosphorylation levels normalized to total proteins in the heart revealed HDAC4 phosphorylation at Ser246 and Ser632 and Erk1/2 phosphorylation at Thr202/Tyr204 were increased in WT mice after hindlimb unloading, but it had no obvious changes in TG mice after hindlimb unloading. The phosphorylation level of AMPK at Thr172 was decreased in WT HU group compared with WT control group, but CKIP-1 TG inhibited this change. These results indicated that myocardial CKIP-1 overexpression inhibited the changes in phosphorylation levels of signal factors in mice heart induced by simulated microgravity.</p>
                <fig id="F5" position="float">
                  <label>Figure 5</label>
                  <caption>
                    <p>Myocardial CKIP-1 overexpression inhibits the phosphorylation of signal factors in mice heart induced by simulated microgravity. <bold>(A)</bold> Representative Western blots for HDAC4 and phosphorylation at Ser246, AMPKα and phosphorylation at (Thr172), and ERK1/2 and phosphorylation at (Thr202/Tyr204) in hearts from WT and CKIP-1 TG mice after 28 days of hindlimb unloading. Gapdh levels served as a loading control. <bold>(B)</bold> Quantification of phosphorylation levels normalized to total protein levels of heart, Values are means ± SEM (<italic>n</italic> = 6), <sup>*</sup><italic>P</italic> &lt; 0.05.</p>
                  </caption>
                  <graphic xlink:href="fphys-09-00040-g0005"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s4">
              <title>Discussion</title>
              <p>Here, we identified CKIP-1 as a novel regulator of simulated microgravity–induced cardiac remodeling. CKIP-1 mRNA and protein levels were significantly downregulated in the hearts of mice after 28 days of hindlimb unloading and rhesus monkeys after 42 days of head-down bed rest. Myocardial CKIP-1 overexpression protected from simulated microgravity induced-decline of cardiac function and loss of left ventricular mass. Histological analysis demonstrated CKIP-1 TG inhibited the decrease in the size of individual cardiomyocytes of mice after hindlimb unloading. Moreover, the pathological cardiac remodeling signals, such as ERK1/2 and HDAC4, were activated, and physiological cardiac remodeling signals, such as AMPK, were inactivated in heart of WT mice after hindlimb unloading, however CKIP-1 TG mice displayed a different trend. Myocardial CKIP-1 overexpression inhibited the changes of phosphorylation levels of signal factors in mice heart induced by simulated microgravity. So, CKIP-1 manifests important functional significance during cardiac stress response resulting from space flight.</p>
              <p>The cardiac muscle is well regulated in response to changes in loading conditions (Hill and Olson, <xref rid="B11" ref-type="bibr">2008</xref>). With prolonged pressure overload, the heart undergoes pathologic hypertrophic remodeling, resulting in dilatation of the failing heart (Hill and Olson, <xref rid="B11" ref-type="bibr">2008</xref>; Ling et al., <xref rid="B17" ref-type="bibr">2017</xref>). Cardiac atrophy was a complication for prolonged microgravity during space flight and mechanical unloading with a ventricular assist device (Levine et al., <xref rid="B15" ref-type="bibr">1997</xref>; Hill and Olson, <xref rid="B11" ref-type="bibr">2008</xref>; Westby et al., <xref rid="B29" ref-type="bibr">2016</xref>). When exposed to 10 days of spaceflight, left ventricular mass decreased by 12 ± 6.9% (Hill and Olson, <xref rid="B11" ref-type="bibr">2008</xref>). After 6 weeks of bed rest, the left ventricular mass decreased by 8.0 ± 2.2%. Thus, cardiac atrophy can be induced by short-term spaceflight or prolonged bed rest (Perhonen et al., <xref rid="B21" ref-type="bibr">2001</xref>). Hindlimb unloading is widely utilized to study the effects of microgravity in mice or rats (Respress et al., <xref rid="B22" ref-type="bibr">2014</xref>; Zhong G. et al., <xref rid="B34" ref-type="bibr">2016</xref>), and head-down tilt bed rest model for non-human primate- rhesus monkeys or human volunteers is also a classical ground-based model of microgravity (Wang et al., <xref rid="B27" ref-type="bibr">2012</xref>; Chen et al., <xref rid="B6" ref-type="bibr">2016</xref>; Ling et al., <xref rid="B17" ref-type="bibr">2017</xref>). The hindlimb of mice are lifted by tail suspension to generate 30-degree head-down tilt for 28 days, and rhesus monkeys were maintained 10-degree head-down tilt position for 42 days. The tilt and unloading of the hindquarters leads to a shift in body fluids toward the head, cardiac remodeling and other physiological changes, which is similar to what is founded in humans during space flight (Zhong G. et al., <xref rid="B34" ref-type="bibr">2016</xref>). In a rodent hindlimb unloading model, the decrease of left ventricular mass occurred within 21 days (Bigard et al., <xref rid="B2" ref-type="bibr">1994</xref>). We previously showed simulated microgravity could induce remodeling of the left and right ventricle of mice (Zhong G. et al., <xref rid="B34" ref-type="bibr">2016</xref>). Cardiac atrophy although is associated with distinct phenotypes (atrophy vs. hypertrophy), generate strikingly similar changes-upregulation of cardiac remodeling marker genes and decline of cardiac function (Depre et al., <xref rid="B8" ref-type="bibr">1998</xref>). As with other form of cardiac remodeling, little is known about the specific mechanism governing the microgravity-induced cardiac atrophy. It is critical to understand the mechanisms regulating cardiac remodeling during microgravity-induced myocardial atrophy in addition to those at play during hypertrophy. Most of the researches suggested that hindlimb unloading can simulate the effect of microgravity which caused a systemic stress, such as fluid shift, and lead to cardiac remodeling and the decline of cardiac function (Watenpaugh, <xref rid="B28" ref-type="bibr">2002</xref>; Zhong G. et al., <xref rid="B34" ref-type="bibr">2016</xref>; Zhong G. H. et al., <xref rid="B33" ref-type="bibr">2016</xref>). In this study, LVPWd of WT mice was decreased following hindlmb unloading, however LVPWd of TG mice after hindlimb unloading did not change, and the value was higher than that in WT mice after hindlimb unloading, TG mice also inhibit the decline of cardiac function induced by simulated microgravity.</p>
              <p>Well-characterized signaling molecules that regulate cardiac remodeling induced by pressure overload include HDAC4 (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>), AMPK (Kovacic et al., <xref rid="B13" ref-type="bibr">2003</xref>), and ERK1/2 (Liu and Hofmann, <xref rid="B18" ref-type="bibr">2004</xref>). HDAC4 shuttles between the cytoplasm and the nucleus in a phosphorylation-dependent manner (Kurdi and Booz, <xref rid="B14" ref-type="bibr">2011</xref>). The nuclear export of HDAC4 can inhibit the transcriptional activity of myocyte enhancer factor-1 (MEF2) which is a master positive regulator of cardiac hypertrophy (Zhang et al., <xref rid="B30" ref-type="bibr">2002</xref>; Kong et al., <xref rid="B12" ref-type="bibr">2006</xref>; Ago et al., <xref rid="B1" ref-type="bibr">2008</xref>). AMPK can regulate cardiac homeostasis, and is a key factor of physiological cardiac remodeling (Schisler et al., <xref rid="B25" ref-type="bibr">2013</xref>; Daskalopoulos et al., <xref rid="B7" ref-type="bibr">2016</xref>). ERK1/2 are members of mitogen-activated protein kinase (MAPK) family, and their activation can regulate pathological cardiac remodeling and heart failure (Ogata et al., <xref rid="B20" ref-type="bibr">2014</xref>; Gu et al., <xref rid="B10" ref-type="bibr">2016</xref>). We previously showed that the pathological cardiac remodeling signals, such as HDAC4 and ERK1/2, were activated, and physiological cardiac remodeling signals, such as AMPK, were inactivated in heart of WT mice after hindlimb unloading (Zhong G. et al., <xref rid="B34" ref-type="bibr">2016</xref>). In the present study, we demonstrated that following 45 days of bed rest, pathological cardiac remodeling signals-ERK1/2 and HDAC4 were activated, and physiological cardiac remodeling signal-AMPK were inactivated in monkey hearts. And the levels of CKIP-1 expression were significantly decreased in the hearts of mice and rhesus monkeys after simulated microgravity. We previously demonstrated that CKIP-1 was a novel regulator of cardiac hypertrophy induced by pressure overload. CKIP-1 TG mice exhibited a strong reduction of pathological cardiac hypertrophy. CKIP-1 functioned as a suppressor of pressure overload-induced cardiac remodeling by upregulating the dephosphorylation and nucleus retention of HDAC4 (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>). CKIP-1 can interact with HDAC4 and PP2A, increases the interaction between HDAC4 and PP2A, and enhances the activity of PP2A, thus promoting the dephosphorylation of HDAC4 (Ling et al., <xref rid="B16" ref-type="bibr">2012</xref>). Moreover, PP2A can also interact with ERK1/2 in cardiomyocytes, PP2A decreases H<sub>2</sub>O<sub>2</sub>-induced ERK1/2 activation (Liu and Hofmann, <xref rid="B18" ref-type="bibr">2004</xref>). CKIP-1 may also inhibit the phosphorylation of ERK1/2 via PP2A. The phosphorylation of AMPK can be negatively regulated by Akt in heart (Kovacic et al., <xref rid="B13" ref-type="bibr">2003</xref>), furthermore, CKIP-1 plays a critical role in the regulation of macrophage homeostasis by inhibiting Akt activation (Zhang et al., <xref rid="B31" ref-type="bibr">2014</xref>). We speculate that CKIP-1 can enhance the phosphorylation of AMPK via inhibiting Akt activity. In this study, CKIP-1 TG prevented from simulated microgravity-induced cardiac atrophy, as evidenced by gravimetric, echocardiographic, and cell size analysis. CKIP-1 TG can inhibit the activation of HDAC4 and ERK1/2 and the inactivation of AMPK in heart of mice induced by simulated microgravity.</p>
              <p>Taken together, our present work has demonstrated that CKIP-1 was a suppressor of cardiac remodeling induced by simulated microgravity. This study provides evidence of the important role of CKIP-1 in cardiac atrophy. These results suggest a novel strategy for positively affecting cardiac remodeling induced by space flight through the upregulation of CKIP-1 in the heart. Nutritional and/or pharmacological interventions may be exploited to prevent cardiac remodeling induced by microgravity via upregulation of CKIP-1 expression in the heart.</p>
            </sec>
            <sec id="s5">
              <title>Author contributions</title>
              <p>YL and SL: conceived the study; YL and GZ: performed the experiment with support from YZ and HL; QX: performed the transthoracic echocardiography; WS, JL, HS, and DC: analyzed and interpreted the results; DZ, JS, XJ, CL, and XY: provided intellectual contribution; XW, YZ, ZL, and QL: performed the statistical analysis; SL: wrote the manuscript; YL: revised the manuscript and gave final approval of the submitted manuscript; All authors have reviewed and approved the final manuscript.</p>
              <sec>
                <title>Conflict of interest statement</title>
                <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="financial-disclosure">
                <p><bold>Funding.</bold> This work was supported by the National Natural Science Foundation of China (No. 31670865, 31300698, and 31325012), Beijing Nova Program (No. Z161100004916111), and 1226 project (No. AWS16J018).</p>
              </fn>
            </fn-group>
            <sec sec-type="supplementary-material" id="s6">
              <title>Supplementary material</title>
              <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2018.00040/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphys.2018.00040/full#supplementary-material</ext-link></p>
              <supplementary-material content-type="local-data" id="SM1">
                <media xlink:href="Presentation1.PDF">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="B1">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ago</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Zhai</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Molkentin</surname><given-names>J. D.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy</article-title>. <source>Cell</source><volume>133</volume>, <fpage>978</fpage>–<lpage>993</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.04.041</pub-id><?supplied-pmid 18555775?><pub-id pub-id-type="pmid">18555775</pub-id></mixed-citation>
              </ref>
              <ref id="B2">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigard</surname><given-names>A. X.</given-names></name><name><surname>Serrurier</surname><given-names>B.</given-names></name><name><surname>Mérino</surname><given-names>D.</given-names></name><name><surname>Lienhard</surname><given-names>F.</given-names></name><name><surname>Guezennec</surname><given-names>C. Y.</given-names></name></person-group> (<year>1994</year>). <article-title>Structural and biochemical properties of the rat myocardium after 21 days of head-down suspension</article-title>. <source>Aviat. Space Environ. Med.</source>
<volume>65</volume>, <fpage>829</fpage>–<lpage>834</lpage>. <?supplied-pmid 7818452?><pub-id pub-id-type="pmid">7818452</pub-id></mixed-citation>
              </ref>
              <ref id="B3">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosc</surname><given-names>D. G.</given-names></name><name><surname>Graham</surname><given-names>K. C.</given-names></name><name><surname>Saulnier</surname><given-names>R. B.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Prober</surname><given-names>D.</given-names></name><name><surname>Gietz</surname><given-names>R. D.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2</article-title>. <source>J. Biol. Chem.</source><volume>275</volume>, <fpage>14295</fpage>–<lpage>14306</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.19.14295</pub-id><?supplied-pmid 10799509?><pub-id pub-id-type="pmid">10799509</pub-id></mixed-citation>
              </ref>
              <ref id="B4">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canton</surname><given-names>D. A.</given-names></name><name><surname>Olsten</surname><given-names>M. E.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Doherty-Kirby</surname><given-names>A.</given-names></name><name><surname>Lajoie</surname><given-names>G.</given-names></name><name><surname>Cooper</surname><given-names>J. A.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein</article-title>. <source>Mol. Cell. Biol.</source><volume>25</volume>, <fpage>3519</fpage>–<lpage>3534</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.25.9.3519-3534.2005</pub-id><?supplied-pmid 15831458?><pub-id pub-id-type="pmid">15831458</pub-id></mixed-citation>
              </ref>
              <ref id="B5">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canton</surname><given-names>D. A.</given-names></name><name><surname>Olsten</surname><given-names>M. E.</given-names></name><name><surname>Niederstrasser</surname><given-names>H.</given-names></name><name><surname>Cooper</surname><given-names>J. A.</given-names></name><name><surname>Litchfield</surname><given-names>D. W.</given-names></name></person-group> (<year>2006</year>). <article-title>The role of CKIP-1 in cell morphology depends on its interaction with actin-capping protein</article-title>. <source>J. Biol. Chem.</source>
<volume>281</volume>, <fpage>36347</fpage>–<lpage>36359</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M607595200</pub-id><?supplied-pmid 16987810?><pub-id pub-id-type="pmid">16987810</pub-id></mixed-citation>
              </ref>
              <ref id="B6">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Pang</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Identification of suitable reference gene and biomarkers of serum miRNAs for osteoporosis</article-title>. <source>Sci. Rep.</source><volume>6</volume>:<fpage>36347</fpage>. <pub-id pub-id-type="doi">10.1038/srep36347</pub-id><?supplied-pmid 27821865?><pub-id pub-id-type="pmid">27821865</pub-id></mixed-citation>
              </ref>
              <ref id="B7">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daskalopoulos</surname><given-names>E. P.</given-names></name><name><surname>Dufeys</surname><given-names>C.</given-names></name><name><surname>Bertrand</surname><given-names>L.</given-names></name><name><surname>Beauloye</surname><given-names>C.</given-names></name><name><surname>Horman</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation</article-title>. <source>J. Mol. Cell. Cardiol.</source>
<volume>91</volume>, <fpage>188</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2016.01.001</pub-id><?supplied-pmid 26772531?><pub-id pub-id-type="pmid">26772531</pub-id></mixed-citation>
              </ref>
              <ref id="B8">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depre</surname><given-names>C.</given-names></name><name><surname>Shipley</surname><given-names>G. L.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Han</surname><given-names>Q.</given-names></name><name><surname>Doenst</surname><given-names>T.</given-names></name><name><surname>Moore</surname><given-names>M. L.</given-names></name><etal/></person-group>. (<year>1998</year>). <article-title>Unloaded heart <italic>in vivo</italic> replicates fetal gene expression of cardiac hypertrophy</article-title>. <source>Nat. Med.</source><volume>4</volume>, <fpage>1269</fpage>–<lpage>1275</lpage>. <pub-id pub-id-type="doi">10.1038/3253</pub-id><?supplied-pmid 9809550?><pub-id pub-id-type="pmid">9809550</pub-id></mixed-citation>
              </ref>
              <ref id="B9">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorfman</surname><given-names>T. A.</given-names></name><name><surname>Levine</surname><given-names>B. D.</given-names></name><name><surname>Tillery</surname><given-names>T.</given-names></name><name><surname>Peshock</surname><given-names>R. M.</given-names></name><name><surname>Hastings</surname><given-names>J. L.</given-names></name><name><surname>Schneider</surname><given-names>S. M.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Cardiac atrophy in women following bed rest</article-title>. <source>J. Appl. Physiol.</source><volume>103</volume>, <fpage>8</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.01162.2006</pub-id><?supplied-pmid 17379748?><pub-id pub-id-type="pmid">17379748</pub-id></mixed-citation>
              </ref>
              <ref id="B10">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Song</surname><given-names>Z. P.</given-names></name><name><surname>Chen</surname><given-names>Y. G.</given-names></name><name><surname>Zhang</surname><given-names>D. D.</given-names></name><name><surname>Wang</surname><given-names>C. Q.</given-names></name></person-group> (<year>2016</year>). <article-title>Rapamycin inhibits cardiac hypertrophy by promoting autophagy via the MEK/ERK/Beclin-1 pathway</article-title>. <source>Front. Physiol.</source>
<volume>7</volume>:<fpage>104</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2016.00104</pub-id><?supplied-pmid 27047390?><pub-id pub-id-type="pmid">27047390</pub-id></mixed-citation>
              </ref>
              <ref id="B11">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>J. A.</given-names></name><name><surname>Olson</surname><given-names>E. N.</given-names></name></person-group> (<year>2008</year>). <article-title>Cardiac plasticity</article-title>. <source>N. Engl. J. Med.</source>
<volume>358</volume>, <fpage>1370</fpage>–<lpage>1380</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra072139</pub-id><?supplied-pmid 18367740?><pub-id pub-id-type="pmid">18367740</pub-id></mixed-citation>
              </ref>
              <ref id="B12">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>Y.</given-names></name><name><surname>Tannous</surname><given-names>P.</given-names></name><name><surname>Lu</surname><given-names>G.</given-names></name><name><surname>Berenji</surname><given-names>K.</given-names></name><name><surname>Rothermel</surname><given-names>B. A.</given-names></name><name><surname>Olson</surname><given-names>E. N.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy</article-title>. <source>Circulation</source><volume>113</volume>, <fpage>2579</fpage>–<lpage>2588</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.625467</pub-id><?supplied-pmid 16735673?><pub-id pub-id-type="pmid">16735673</pub-id></mixed-citation>
              </ref>
              <ref id="B13">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacic</surname><given-names>S.</given-names></name><name><surname>Soltys</surname><given-names>C. L.</given-names></name><name><surname>Barr</surname><given-names>A. J.</given-names></name><name><surname>Shiojima</surname><given-names>I.</given-names></name><name><surname>Walsh</surname><given-names>K.</given-names></name><name><surname>Dyck</surname><given-names>J. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume>, <fpage>39422</fpage>–<lpage>39427</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M305371200</pub-id><?supplied-pmid 12890675?><pub-id pub-id-type="pmid">12890675</pub-id></mixed-citation>
              </ref>
              <ref id="B14">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurdi</surname><given-names>M.</given-names></name><name><surname>Booz</surname><given-names>G. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Three 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC</article-title>. <source>J. Mol. Cell. Cardiol.</source>
<volume>50</volume>, <fpage>964</fpage>–<lpage>971</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.02.004</pub-id><?supplied-pmid 21320507?><pub-id pub-id-type="pmid">21320507</pub-id></mixed-citation>
              </ref>
              <ref id="B15">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>B. D.</given-names></name><name><surname>Zuckerman</surname><given-names>J. H.</given-names></name><name><surname>Pawelczyk</surname><given-names>J. A.</given-names></name></person-group> (<year>1997</year>). <article-title>Cardiac atrophy after bed-rest deconditioning: a nonneural mechanism for orthostatic intolerance</article-title>. <source>Circulation</source>
<volume>96</volume>, <fpage>517</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.96.2.517</pub-id><?supplied-pmid 9244220?><pub-id pub-id-type="pmid">9244220</pub-id></mixed-citation>
              </ref>
              <ref id="B16">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>CKIP-1 inhibits cardiac hypertrophy by regulating class II histone deacetylase phosphorylation through recruiting PP2A</article-title>. <source>Circulation</source><volume>126</volume>, <fpage>3028</fpage>–<lpage>3040</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.102780</pub-id><?supplied-pmid 23151343?><pub-id pub-id-type="pmid">23151343</pub-id></mixed-citation>
              </ref>
              <ref id="B17">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>S.</given-names></name><name><surname>Zhong</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Liang</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Circulating microRNAs correlated with bone loss induced by 45 days of bed rest</article-title>. <source>Front. Physiol.</source><volume>8</volume>:<fpage>69</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2017.00069</pub-id><?supplied-pmid 28261104?><pub-id pub-id-type="pmid">28261104</pub-id></mixed-citation>
              </ref>
              <ref id="B18">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Hofmann</surname><given-names>P. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes</article-title>. <source>Am. J. Phys. Heart Circ. Physiol.</source>
<volume>286</volume>, <fpage>H2204</fpage>–<lpage>H2212</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.01050.2003</pub-id><?supplied-pmid 14962831?><pub-id pub-id-type="pmid">14962831</pub-id></mixed-citation>
              </ref>
              <ref id="B19">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>R. W.</given-names></name><name><surname>Guan</surname><given-names>H. P.</given-names></name><name><surname>Ehrhart</surname><given-names>J.</given-names></name><name><surname>Petrov</surname><given-names>A.</given-names></name><name><surname>Prahalada</surname><given-names>S.</given-names></name><name><surname>Tozzo</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy</article-title>. <source>Science</source><volume>357</volume>, <fpage>507</fpage>–<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1126/science.aah5582</pub-id><?supplied-pmid 28705990?><pub-id pub-id-type="pmid">28705990</pub-id></mixed-citation>
              </ref>
              <ref id="B20">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>T.</given-names></name><name><surname>Naito</surname><given-names>D.</given-names></name><name><surname>Nakanishi</surname><given-names>N.</given-names></name><name><surname>Hayashi</surname><given-names>Y. K.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name><name><surname>Miyagawa</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by alpha1-adrenergic receptors</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>111</volume>, <fpage>3811</fpage>–<lpage>3816</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1315359111</pub-id><?supplied-pmid 24567387?><pub-id pub-id-type="pmid">24567387</pub-id></mixed-citation>
              </ref>
              <ref id="B21">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perhonen</surname><given-names>M. A.</given-names></name><name><surname>Franco</surname><given-names>F.</given-names></name><name><surname>Lane</surname><given-names>L. D.</given-names></name><name><surname>Buckey</surname><given-names>J. C.</given-names></name><name><surname>Blomqvist</surname><given-names>C. G.</given-names></name><name><surname>Zerwekh</surname><given-names>J. E.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Cardiac atrophy after bed rest and spaceflight</article-title>. <source>J. Appl. Physiol.</source><volume>91</volume>, <fpage>645</fpage>–<lpage>653</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.2001.91.2.645</pub-id><?supplied-pmid 11457776?><pub-id pub-id-type="pmid">11457776</pub-id></mixed-citation>
              </ref>
              <ref id="B22">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Respress</surname><given-names>J. L.</given-names></name><name><surname>Gershovich</surname><given-names>P. M.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Reynolds</surname><given-names>J. O.</given-names></name><name><surname>Skapura</surname><given-names>D. G.</given-names></name><name><surname>Sutton</surname><given-names>J. P.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Long-term simulated microgravity causes cardiac RyR2 phosphorylation and arrhythmias in mice</article-title>. <source>Int. J. Cardiol.</source><volume>176</volume>, <fpage>994</fpage>–<lpage>1000</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2014.08.138</pub-id><?supplied-pmid 25227892?><pub-id pub-id-type="pmid">25227892</pub-id></mixed-citation>
              </ref>
              <ref id="B23">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruppert</surname><given-names>C.</given-names></name><name><surname>Deiss</surname><given-names>K.</given-names></name><name><surname>Herrmann</surname><given-names>S.</given-names></name><name><surname>Vidal</surname><given-names>M.</given-names></name><name><surname>Oezkur</surname><given-names>M.</given-names></name><name><surname>Gorski</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>110</volume>, <fpage>7440</fpage>–<lpage>7445</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1221999110</pub-id><?supplied-pmid 23589880?><pub-id pub-id-type="pmid">23589880</pub-id></mixed-citation>
              </ref>
              <ref id="B24">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safi</surname><given-names>A.</given-names></name><name><surname>Vandromme</surname><given-names>M.</given-names></name><name><surname>Caussanel</surname><given-names>S.</given-names></name><name><surname>Valdacci</surname><given-names>L.</given-names></name><name><surname>Baas</surname><given-names>D.</given-names></name><name><surname>Vidal</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation</article-title>. <source>Mol. Cell. Biol.</source><volume>24</volume>, <fpage>1245</fpage>–<lpage>1255</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.24.3.1245-1255.2004</pub-id><?supplied-pmid 14729969?><pub-id pub-id-type="pmid">14729969</pub-id></mixed-citation>
              </ref>
              <ref id="B25">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schisler</surname><given-names>J. C.</given-names></name><name><surname>Rubel</surname><given-names>C. E.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Lockyer</surname><given-names>P.</given-names></name><name><surname>Cyr</surname><given-names>D. M.</given-names></name><name><surname>Patterson</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>CHIP protects against cardiac pressure overload through regulation of AMPK</article-title>. <source>J. Clin. Invest.</source>
<volume>123</volume>, <fpage>3588</fpage>–<lpage>3599</lpage>. <pub-id pub-id-type="doi">10.1172/JCI69080</pub-id><?supplied-pmid 23863712?><pub-id pub-id-type="pmid">23863712</pub-id></mixed-citation>
              </ref>
              <ref id="B26">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuday</surname><given-names>E. C.</given-names></name><name><surname>Berkowitz</surname><given-names>D. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Microgravity and cardiac atrophy: no sex discrimination</article-title>. <source>J. Appl. Physiol.</source>
<volume>103</volume>, <fpage>1</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00010.2007</pub-id><?supplied-pmid 17363626?><pub-id pub-id-type="pmid">17363626</pub-id></mixed-citation>
              </ref>
              <ref id="B27">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Tam</surname><given-names>K. F.</given-names></name><name><surname>Ling</surname><given-names>S.</given-names></name><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Resistive vibration exercise retards bone loss in weight-bearing skeletons during 60 days bed rest</article-title>. <source>Osteoporos. Int.</source><volume>23</volume>, <fpage>2169</fpage>–<lpage>2178</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-011-1839-z</pub-id><?supplied-pmid 22159820?><pub-id pub-id-type="pmid">22159820</pub-id></mixed-citation>
              </ref>
              <ref id="B28">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watenpaugh</surname><given-names>D. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Nocturnal lower body positive pressure to counteract microgravity-induced cardiac remodeling/atrophy</article-title>. <source>J. Appl. Physiol.</source>
<volume>92</volume>, <fpage>2222</fpage>–<lpage>2223</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.01016.2001</pub-id><?supplied-pmid 12008648?><pub-id pub-id-type="pmid">12008648</pub-id></mixed-citation>
              </ref>
              <ref id="B29">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westby</surname><given-names>C. M.</given-names></name><name><surname>Martin</surname><given-names>D. S.</given-names></name><name><surname>Lee</surname><given-names>S. M.</given-names></name><name><surname>Stenger</surname><given-names>M. B.</given-names></name><name><surname>Platts</surname><given-names>S. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Left ventricular remodeling during and after 60 days of sedentary head-down bed rest</article-title>. <source>J. Appl. Physiol.</source>
<volume>120</volume>, <fpage>956</fpage>–<lpage>964</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00676.2015</pub-id><?supplied-pmid 26494448?><pub-id pub-id-type="pmid">26494448</pub-id></mixed-citation>
              </ref>
              <ref id="B30">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C. L.</given-names></name><name><surname>McKinsey</surname><given-names>T. A.</given-names></name><name><surname>Chang</surname><given-names>S.</given-names></name><name><surname>Antos</surname><given-names>C. L.</given-names></name><name><surname>Hill</surname><given-names>J. A.</given-names></name><name><surname>Olson</surname><given-names>E. N.</given-names></name></person-group> (<year>2002</year>). <article-title>Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy</article-title>. <source>Cell</source>
<volume>110</volume>, <fpage>479</fpage>–<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(02)00861-9</pub-id><?supplied-pmid 12202037?><pub-id pub-id-type="pmid">12202037</pub-id></mixed-citation>
              </ref>
              <ref id="B31">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Xing</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation</article-title>. <source>Cell Res.</source><volume>24</volume>, <fpage>742</fpage>–<lpage>761</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2014.53</pub-id><?supplied-pmid 24777252?><pub-id pub-id-type="pmid">24777252</pub-id></mixed-citation>
              </ref>
              <ref id="B32">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Xing</surname><given-names>G.</given-names></name><name><surname>Tie</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Tian</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Role for the pleckstrin homology domain-containing protein CKIP-1 in AP-1 regulation and apoptosis</article-title>. <source>EMBO J.</source><volume>24</volume>, <fpage>766</fpage>–<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600532</pub-id><?supplied-pmid 15706351?><pub-id pub-id-type="pmid">15706351</pub-id></mixed-citation>
              </ref>
              <ref id="B33">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>G. H.</given-names></name><name><surname>Ling</surname><given-names>S. K.</given-names></name><name><surname>Li</surname><given-names>Y. X.</given-names></name></person-group> (<year>2016</year>). <article-title>[Mechanism of cardiac atrophy under weightlessness/simulated weightlessness]</article-title>. <source>Sheng Li Xue Bao</source>
<volume>68</volume>, <fpage>194</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.13294/j.aps.2016.0023</pub-id><?supplied-pmid 27108907?><pub-id pub-id-type="pmid">27108907</pub-id></mixed-citation>
              </ref>
              <ref id="B34">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Cao</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Simulated microgravity and recovery-induced remodeling of the left and right ventricle</article-title>. <source>Front. Physiol.</source><volume>7</volume>:<fpage>274</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2016.00274</pub-id><?supplied-pmid 27445861?><pub-id pub-id-type="pmid">27445861</pub-id></mixed-citation>
              </ref>
              <ref id="B35">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Ouyang</surname><given-names>Y.</given-names></name><name><surname>Zhong</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Ding</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkin's lymphoma</article-title>. <source>Oncol. Rep.</source><volume>37</volume>, <fpage>622</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.3892/or.2016.5233</pub-id><?supplied-pmid 27840970?><pub-id pub-id-type="pmid">27840970</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
